Table 1 |
||||
|
Chemoprophylactic effect of azithromycin monotherapy against Plasmodium falciparum in semi-immune non-pregnant adults. |
||||
|
Country |
Treatment regimen |
Sample size |
Duration of follow-up |
Chemoprophylactic effect (95% CI) |
|
|
||||
|
Kenya [40] |
250 mg daily |
59 |
10 weeks |
83% (68–91) |
|
|
||||
|
Kenya [40] |
1,000 mg weekly |
58 |
10 weeks |
64% (47–77) |
|
|
||||
|
Indonesia [36] |
750 mg loading dose and 250 mg daily |
148 |
20 weeks |
72% (50–84) |
|
|
||||
|
Thailand [37] |
750 mg loading dose and 250 mg daily |
179 |
20 weeks |
71% (-14–94) |
|
|
||||
|
Chico et al. Malaria Journal 2008 7:255 doi:10.1186/1475-2875-7-255 |
||||
